Free tool
FAERS Monitor: Cis-Pyro
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019039 or its brand name (Cis-Pyro, Technetium Tc-99m Pyrophosphate Kit). Reports on generic versions are filed under their own applications.
Reports
4
Serious
1
25% of reports
Hospitalization
0
Death reported
1
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- abdominal distension1
- condition aggravated1
- drug level changed1
- dyspnoea1
- flushing1
- headache1
- jaundice1
- pain1
- resuscitation1
- urticaria1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2014 | 1 |
| 2015 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,155 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug level changed | 1 | 8368.1 | 1529.9 | 2,088 |
| resuscitation | 1 | 3174.6 | 581.1 | 792 |
| jaundice | 1 | 195.5 | 35.8 | 48 |
| flushing | 1 | 51.7 | 9.5 | 12 |
| abdominal distension | 1 | 50.4 | 9.2 | 12 |
| urticaria | 1 | 31.4 | 5.7 | 7 |
| condition aggravated | 1 | 17.3 | 3.2 | 3 |
| dyspnoea | 1 | 9.3 | 1.7 | 1 |
| pain | 1 | 8.6 | 1.6 | 1 |
| headache | 1 | 8.4 | 1.5 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.